DE40: DAX gains slightly ahead of US CPI report 💡

1:27 pm 11 July 2024

  • European indices gain slightly in the first phase of Thursday's session
  • Investors await U.S. CPI data at 1:30 p.m. BST
  • Suedzucker falls to lowest level since April, after the company reported first-quarter operating profit that missed analysts' estimates

Overall market situation:

Thursday's session on European capital markets moderate increases in the quotations of stock indices. At the time of this writing, Germany's DAX is gaining nearly 0.2%, France's CAC40 is adding 0.45%, and Britain's FTSE 100 is up 0.37%. Investors are eagerly awaiting the CPI report from the US, which will be released at 1:30 pm BST. 

The revision of CPI data from Germany did not surprise and pointed to data readings in line with expectations.

Volatility currently observed in the DAX index. Source: Bloomberg Financial LP

Volatility currently observed in the broad European market. Source: xStation

The German benchmark DE40 is trading during the first phase of Thursday's session near yesterday's closing levels. The whole index is trying to negate the structure of the downward trend initiated on May 16. The continuation of the downtrend led to the testing of a historically important support level in the zone of the 100-day exponential moving average (purple curve on the chart, all the while it remains a key support point). Locally, the most important resistance, after piercing the 50-day EMA (blue curve), is now the zone of the July 5 peak (combined with the peak of April 2 this year). A possible breakthrough of this zone could encourage the demand side to test the historical peaks in the 19,000-point zone. Source: xStation

News:  

Suedzucker (SZU.DE) is losing more than 3.3% today and falling to its lowest level since April, after the company reported first-quarter operating profit that missed analysts' estimates. What's more, investment bankers believe the company's negative earnings growth will continue for the next few quarters.

The company largely struggled with higher sugar production costs. 

FIRST QUARTER RESULTS

  • Operating profit 155 million euros, estimated 167.3 million euros
  • Sugar unit's operating profit 59 million euros, estimated 64.2 million euros 
  • Special products unit operating profit 57 million euros, estimated 50.5 million euros 
  • CropEnergies operating profit 6 million euros, estimated 9.52 million euros
  • Starch operating profit 6 million euros, estimated 12.4 million euros
  • Fruit operating profit 27 million euros, estimated 22.2 million euros
  • Ebitda 230 million euros, estimated 242 million euros
  • Revenues €2.55 billion, estimated €2.58 billion
  • Sugar unit revenues €1.08 billion, estimated €1.02 billion
  • Special products revenue €579 million, estimated €595.7 million 
  • CropEnergies revenue 231 million euros, estimated 250.2 million euros 
  • Revenue from starch 250 million euros, estimated 269.6 million euros 
  • Fruit revenues €415 million, estimated €403 million 

Gerresheimer (GXI.DE) shares rose as much as 4.9%, before easing to a 1.3% gain, after the medical packaging company reported adjusted Ebitda for the second quarter that exceeded analysts' estimates

SECOND QUARTER RESULTS

  • Adjusted Ebitda 107.3 million euros, estimated 105.1 million euros
  • Plastics and equipment adjusted Ebitda 78.8 million euros, estimated 73.9 million euros
  • Packaging glass adjusted Ebitda 39.5 million euros, estimated 43.6 million euros
  • Advanced technologies adjusted Ebitda loss €3.5 million, estimated loss €3.26 million
  • Adjusted Ebitda margin 21.4%, estimated 20.2%
  • Adjusted net income €43.5 million, estimated €38.1 million
  • Adjusted earnings per share (EPS) €1.24 million, estimate €1.15 million
  • Revenues 502.4 million euros, estimate 508 million euros
  • Plastics and equipment revenue 283.1 million euros, estimate 288 million euros
  • Revenues from container glass 218.1 million euros, estimate 225.8 million euros
  • Revenue from advanced technology €2.2 million, estimate €2.45 million

DNB Bank (DNB.NO) jumped as much as 5.8%, the most since November 2020, After the Norwegian lender reported an "impressive" second-quarter result. The bank's net income rose 12% to 10.3 billion kroner ($960 million) in the three months through June, beating analysts' estimates of 9.3 billion kroner. A 60% increase in revenue from investment banking services boosted net commissions and fees to 3.4 billion kroner for the quarter.

Investment banking fee and commission earnings surprised investors particularly well. Source: Bloomberg Financial LP

Other news coming out of individual companies in the DAX index. Source: Bloomberg Financial LP

The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.

Share:
Back

Join over 1 600 000 XTB Group Clients from around the world.